ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - Pralsetinib in Patients (pts) With Advanced or Metastatic RET-Altered Thyroid Cancer (TC): Updated Data From the ARROW Trial
By
ASCO 2022 Conference Coverage
FEATURING
Lori Wirth
By
ASCO 2022 Conference Coverage
FEATURING
Lori Wirth
11 views
July 14, 2022
Login to view comments.
Click here to Login
Lung